Memorial Sloan Kettering Cancer Center in New York City has appointed two oncology chiefs.

Separately, oncologist Thomas Weiner, a former employee, also faces a civil suit, which alleges he overbilled the government for cancer services and overprescribed medications, among other claims.

University of Michigan Health-West has named a new chief medical officer.  Dr. Clifford Cho was appointed CMO of University of Michigan Health-West in May 2024.

The new executive director of New York Oncology Hematology is Allyson Letendre Petrone, the physician group announced Monday.

This report is a review of recent and emerging trends that promise to make radiation oncology for prostate cancer more ...

Advances in treatment and new drugs are pushing cancer care even farther away from hospital campuses into outpatient settings ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--TheRas, Inc. d/b/a BridgeBio Oncology Therapeutics (“BBOT” or the “Company”), a clinical-stage precision oncology company, has announced the appointment ...

Newly appointed CMO, Dr. Emmanuelle Dochy, and newly appointed CSO, Dr. Maurizio Ceppi, bring a strong track record of advancing cancer ...

L.C. proudly announces the appointment of Dr. Rico Buchli as Chief Scientist. In his new role, Dr. Buchli will ...

In terms of valuation, Kura Oncology Inc’s market capitalization stands at $1.51 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market ...

Mack Roach, III, MD, FASTRO, has been chosen by the American Society for Radiation Oncology (ASTRO) to receive its 2024 Gold Medal Award. Roach is being recognized with ASTRO’s highest honor for his ...